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BACKGROUND
Cerebral palsy (CP) comprises a group of neurological disor-
ders resulting from malformation in the developing brain or 
nonprogressive brain injury occurring during or soon after 
birth. CP is the most common childhood disability, with a 
reported prevalence of 2-3 per 1000 live births (1). Physi-
cal disability in CP is mainly due to motor impairment, and 
manifests as poor muscle control, weakness, hypertonicity, 
spasticity, and balance disorders. The motor impairment 
frequently leads to contractures of muscle-tendon units 
with consequent reduction of the range of motion (RoM) of 
joints. Contracture most commonly affects the ankle plan-
tar flexors, leading to equinus foot deformity. Contractures 
are not solely due to muscle overactivation; increased intrin-
sic passive stiffness of the tissue also contributes (2). Thus, 
increased muscle stiffness in CP has two components: active 
and passive. Active (neural) muscle stiffness is mainly relat-
ed to spasticity, which is due to velocity-dependent exces-
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SUMMARY
Background. Muscle spasticity causes disability in children with cerebral palsy. Extracorpore-
al shockwave therapy has proved to be effective in managing hypertonic muscles. Shear wave 
elastography can objectively assess tissue elasticity properties. The aim of the present study 
was to 1) evaluate the effectiveness of defocused extracorporeal shockwaves in reducing sole-
us muscle contracture in a group of children with cerebral palsy by using point shear wave 
elastography, and 2) analyse the correlation between the Modified Ashworth Scale and ultra-
sound elasticity index. Methods. Children with spastic cerebral palsy (n = 21) were adminis-
tered extracorporeal shockwave therapy (5 sessions at weekly interval, 500 defocused shock-
waves per session, 0.25 mJ/mm2, 3 Hz). The effects were measured by means of point shear 
wave elastography 1, 3, and 6 months after therapy. Results. Linear mixed effects modelling 
showed significant reduction of muscle stiffness, with the predicted greatest effect at the 13th 
week after completion of treatment. Analysis of covariance confirmed the correlation between 
the Modified Ashworth Scale and ultrasound elasticity index. Conclusions. Point shear wave 
elastography confirmed the effectiveness of defocused extracorporeal shockwaves in reducing 
muscles contracture in children with cerebral palsy. We recommend the use of this technique 
for the clinical assessment of spastic patients.
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sive muscle activation resulting from hyperexcitability of 
the stretch reflex. By contrast, passive (non-neural) muscle 
stiffness is due to the viscoelastic properties of muscles (3). 
On clinical examination, active muscle stiffness is exhibited 
when the muscle is contracting, while passive muscle stiff-
ness is exhibited when myofibers are not actively contract-
ing. The source of active muscle stiffness is the contrac-
tile cells, while the source of passive muscle stiffness is the 
connective tissue and extracellular matrix.
While muscle contracture may play a limited positive role in 
CP by compensating for muscle weakness, it has an overall 
negative effect on mobility control and function. Contrac-
tures may also affect musculoskeletal development and lead 
to skeletal deformities, joint dislocations, and scoliosis.
Treatment of muscle contractures can be a major challenge 
in children with CP. The treatment strategy depends on 
the nature of stiffness (active, passive, or mixed) and on 
the degree and location of functional impairment. Treat-
ment options include oral medication (baclofen, diazepam, 
clonazepam, dantrolene, and tizanidine), physical and occu-
pational therapy, splinting and casting, chemodenervation 
with botulinum toxin or phenol, selective dorsal rhizotomy, 
intrathecal baclofen, and orthopaedic surgery.
A new treatment option could be extracorporeal shock-
wave therapy (ESWT), which has been found to be high-
ly effective in chronic soft tissue injuries and certain bone 
conditions (4). ESWT can be applied using focused or 
defocused extracorporeal shockwaves. The two types 
differ in focal zone localization, inside the human body and 
inside the therapy head of the device, respectively. Defo-
cused shockwaves exert their effect at the body surface 
and are preferred for treatment of muscular disorders. 
In recent years, defocused shock wave therapy has been 
considered as an effective treatment modality in regener-
ation medicine (5). However, the underlying mechanisms 
of beneficial effect of defocused shock waves are not yet 
completely understood. Previous studies suggested that 
upregulated neovascularization (6), neuroregeneration 
(7), enzymatic activities (8), anti-inflammatory effect (9), 
and recruitment of endogenous mesenchymal stromal cells 
(MSCs) (10) might be involved in the process. Over the last 
few years several studies have found ESWT to be effective 
for treating muscle contractures in children with CP via its 
neuromodulatory and rheological effects (11-15). Howev-
er, until now only subjective or operator-dependent assess-
ment tools have been used in order to measure the effects 
of ESWT on spastic muscles. Here, it is necessary to clarify 
that radial pressure waves are another kind of waves which 
definitely differ from extracorporeal shock waves in gener-
ation, mechanism of action and indications. Moreover, also 
radial pressure waves are used to treat muscle contractures.
Measurement of muscle stiffness is difficult. Ordinal 
scales such as the Ashworth Scale (AS) and the Modified 
Ashworth Scale (MAS) are easy to apply but lack reliability 
and do not measure the passive component of muscle stiff-
ness (16). Recent advances in ultrasound (US) elastography 
techniques have now made direct quantification of muscle 
stiffness possible. US elastography is a noninvasive imaging 
technique that measures tissue displacement (i.e., strain) 
in response to the application of a given force. There are 
several US elastography methods available, depending on 
how the force is applied; two commonly used methods are 
transient elastography (TE), which uses mechanical exter-
nal vibration, and shear wave elastography (SWE), which 
uses acoustic radiation force impulse (ARFI). All elastogra-
phy methods allow to measure the Strain Ratio (SR), which 
is used when the force applied in elastography is not known. 
SR is calculated by dividing the average strain in the region 
of interest (ROI) by the average strain in the reference 
normal tissue. SR is a dimensionless quantity and is gener-
ally expressed as a fraction with a number between 0 and 1. 
The higher SR is, the more stiff the tissue. In SWE, ARFI 
creates shear waves that travel perpendicularly through the 
tissue. These waves can be tracked for a limited distance. 
The velocity of the propagating shear waves is more in hard-
er than in softer tissue, and this property is made use of for 
evaluating tissue stiffness (17). The relationship between the 
applied force and the resulting strain, which is expressed 
as either shear wave velocity (m/s) or as the elasticity index 
(EI), also called Young’s modulus (kPa), quantifies tissue 
elasticity (17). The higher the EI, the more stress is needed 
to create the same amount of strain; an idealized rigid body 
would have an infinite EI. The visual representation of tissue 
elasticity and the possibility to perform quantitative assess-
ment of recorded tissue elasticity allows to further catego-
rize SWE into Point Shear Wave Elastography (P-SWE) 
and 2D Shear Wave Elastography (2D-SWE).
P-SWE is a recently introduced form of SWE. It can be 
incorporated into high-end ultrasound equipment, allow-
ing B-mode ultrasound elastography measurements. The 
technique has many advantages: it is an operator-indepen-
dent, relatively reproducible, quantitative method for the 
evaluation of muscle tissue properties (18). The usefulness 
of P-SWE for measurement of muscle stiffness in children 
with CP has been demonstrated by Vola and co-authors in 
2018 (19).
In this experimental study we aimed to 1) evaluate the 
effects of extracorporeal defocused shockwaves on soleus 
muscle contracture in children with hemiplegic CP by using 
two clinical measurements (MAS and ankle pRoM) and two 
P-SWE interpretation parameters (SR and EI), and 2) anal-
yse the correlation between MAS scores and EI.
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MATERIALS AND METHODS
A total of 21 children (15 male and 6 female; age range, 
3-16 years) with hemiplegic CP were recruited from the 
Federico II University Outpatient Rehabilitation Centre of 
Naples, Italy. 
In order to compute the sample size for a minimum power 
of 0.80, we performed a simulation as suggested by Benja-
min et al. (20). We repeated each simulation 5000 times 
per sample size. It turned out that a minimum of 4 subjects 
was sufficient for testing the hypothesis of parabolic trend 
with subject-dependent intercept, with respect to a constant 
trend. The sample size required to test the same hypoth-
esis with respect to other trends (linear or parabolic, with 
subject-dependent coefficients) is 2. In these last cases the 
power remains always higher than 0.9.
The study was carried out in accordance with the 7th revi-
sion of the Declaration of Helsinki and informed consent 
for the processing of the personal data was provided in 
advance with appropriate, written documentation by 
parent/guardian/tutor. Privacy and confidentiality were 
completely guaranteed (21). Inclusion criteria were 1) veri-
fied diagnosis of CP with unilateral spastic equinus foot 
deformity; 2) walking ability, with or without aids; 3) abil-
ity to follow instructions; 4) dynamic ankle plantar flex-
ion contractures (confirmed if foot equinus deformity was 
observed during ambulation); and 5) spasticity of plan-
tar flexor muscles greater than grade 1 and up to grade 4 
according to the MAS. The exclusion criteria were 1) previ-
ous surgery at the level of feet, ankles, or legs; 2) botuli-
num toxin injections in the preceding 6 months; 3) current 
treatment with spasticity medications or drugs which could 
influence muscle activity; 4) clinical signs of myopathy or 
neuropathy; 5) serious blood dyscrasia or clotting disorder; 
6) infection or cancer at the site of therapy application. 
We decided to analyse the effects of defocused shockwaves 
on the soleus because it is a monoarticular muscle and its 
sole function is plantar flexion. In contrast, the gastrocne-
mius, which is the other plantar flexion muscle, also contrib-
utes to knee flexion. So, with the knee flexed, the soleus 
muscle becomes the main plantar flexion muscle. Further-
more, due to its deep anatomical position the soleus is more 
suitable than the gastrocnemius muscle for ultrasound eval-
uation with a convex transducer.
Clinical and ultrasonographic assessments were performed 
before the first treatment session (T0), and immediately 
(T1-5th week), 1 month (T2-9th week), 3 months (T3-17th 
week), and 6 months (T4-29th week) after the last treatment 
session. The first evaluation was in June–July 2017 and the 
last one in January-February 2018. At each follow-up, the 
children underwent a comprehensive clinical examination 
(including maximum ankle dorsiflexion measurement and 
MAS) by a physiatrist specialized in paediatric rehabilita-
tion and an ultrasound examination (P-SWE) performed by 
a radiologist with expertise in musculoskeletal ultrasound. 
In each patient the same physiatrist applied the shockwave 
therapy and performed the clinical evaluation.
Ultrasonographic and clinical evaluations were performed 
always under the same environmental conditions, that is to 
say at a temperature between 20 and 22 °C (climate-con-
trolled room) and in the morning. 
Maximum ankle dorsiflexion (pRoM) was assessed using a 
goniometer. Measurement was performed with the patient 
in the supine position, with the knee flexed at 90°. Spasticity 
of the soleus was measured using MAS. 
Each child received one ESWT session per week for 5 
consecutive weeks. Therapy was performed with an elec-
tromagnetic shockwave device (Duolith® SD1, Storz 
Medical AG, Taegerwillen, Switzerland) that produc-
es defocused shockwaves by means of the C-ACTOR® 
II handpiece. Defocused shockwaves have short wave-
lengths, with their focal zone inside the therapy head of 
the device. Defocused shockwaves exert their effects at the 
body surface and are preferred for treatment of muscular 
disorders. A total of 500 defocused shockwaves were used 
to treat each hypertonic soleus muscle. For each treatment 
an energy level of 0.25 mJ/mm2 at a frequency of 3 Hz 
was applied. ESWT was repeatedly performed at the same 
anatomical site as the P-SWE evaluation, i.e., at the prox-
imal one-third of the soleus on a longitudinal line running 
from a point midway between medial and lateral epicon-
dyles of the femur to the calcaneal tuberosity. During ther-
apy the child was positioned prone, with the legs stretched 
out on the table. An ultrasound gel was applied on the 
skin at the site of placement of the head of the device. No 
anaesthesia or analgesia was used. 
All children received physiotherapy concurrently with 
ESWT (60-minute sessions, every other day). Physiotherapy 
was carried out by licensed physical therapists and consist-
ed of positioning, stretching exercises, massages, proprio-
ceptive neuromuscular facilitation (Bobath technique) and 
sensory integration therapy. However, it should be point-
ed out that physical therapy was already performed before 
ESWT and went on after the treatment as well.
The radiologist performed P-SWE using a Samsung RS80A 
ultrasound scanner with Prestige equipment (Samsung 
Medison Co. Ltd., Seoul, Korea), interfaced with a convex 
array transducer (CA1-7; Samsung Medison Co. Ltd., 
Seoul, Korea), and equipped with Smart Shear Wave Elas-
tography (S-SWE) software (figure 1). The S-SWE method 
had a unique performance index, Reliability Measurement 
Index (RMI), which is calculated by the weighted sum of 
the residual of the wave equation and the magnitude of the 
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shear wave. RMI ranging from 0.0-1.0, where 0.4 or higher 
is considered as acceptable whilst 1.0 is considered a very 
high value of RMI, and strongly correlates with reproduc-
ible measurements, according to the manufacturer. The 
proposed index is utilized to filter out unreliable measure-
ments and results in performance improvement of shear 
wave elastography. Although several sources of system-de-
pendent bias exist for each type of shear wave elastography, 
a recent phantom study has compared the S-SWE to other 
novel shear wave methods, demonstrating a similar and 
excellent inter- and intra-observer repeatability (22).
During examination the child was in the prone position, with 
the feet dangling over the edge of the examination table. 
Ultrasound measurement was performed over the middle 
third of the soleus muscle, where the muscle bulk is great-
est and no fascial borders, tendons, and major blood vessels 
are present. The transducer was aligned transversally to the 
direction of the muscle fibers. B-mode imaging was used to 
confirm correct placement of the transducer. The transducer 
was held in place with minimal pressure on the skin.
STATISTICAL METHODS
Statistical analysis was performed using R (http://
www.R-project.org/). Linear mixed effects (LME) model-
ling was used to analyse the changes over time of SR, EI, and 
ankle pRoM (23). This method is suitable when there are 
repeated measures on the same patient. The classical analy-
sis of variance (ANOVA) cannot be applied because of the 
correlation that exists between measurements in the same 
patient. A preliminary analysis showed that a second-order 
polynomial (such as y(t) = A × t2 + B × t + C) might be 
an appropriate fitting per each patient. Specifically, we test-
ed the hypothesis that all patients could be described by 
polynomials, differing only for the constant C (that might 
depend on the initial value of the stiffness for that patient). 
Therefore, we assumed A and B as fixed effects and C as 
random effect; thus, the complete model can be described 
by the equation y(j,k) = A × k2 + B × k + C(j) + e(j,k), where 
y(j,k) is the measurement on the j subject at time k; C(j) is 
the constant coefficient of the j-th patient while e(j,k) is the 
error term at time k for the j-th patient. We assumed that 
C(j) is normally distributed with variance ΣC2 and diago-
nal covariance matrix; e(j,k) is normal with diagonal cova-
riance matrix and variance sigma^2. This model has been 
tested against two other models: A fixed, B and C random 
with diagonal covariance matrix; A, B, and C random with 
diagonal covariance matrix. To investigate the relationship 
between EI and MAS the repeated-measures correlation 
approach was used (24). The classical Pearson correlation 
coefficient cannot be applied, because the condition of data 
independence is not satisfied and within-subject correlation 
must be taken into account. The repeated-measures correla-
tion method is based on analysis of covariance (ANCOVA) 
and provides the best fit for each subject, with parallel lines 
and variable intercepts. Currently an implementation of 
this approach is contained in the rmcorr package in R. The 
repeated-measures correlation coefficient was calculated, 
with the confidence interval (calculated with bootstrap on 
1000 repetitions) and the p value.
RESULTS 
Figures 2 and 3 show the EI vs. time relationship, repre-
sented as mean and individual measurements respectively. 
As figure 2 shows, minimum stiffness was measured at the 
9th week after completion of treatment, and then EI mean 
value progressively returned to pre-treatment status. The 
beneficial effects of ESWT disappeared at the 24th week 
approximately. Figure 3 shows that LME modelling gives a 
reasonable approximation of the measured data. A formal 
analysis of LME gave a residual standard deviation of 0.482; 
the coefficients of the second-order polynomial were 7.95, 
-0.278, 0.0104 (mean of the random C, fixed B and A, 
respectively), while the standard deviation of the random 
effect (C) was 1.49. The comparison of this model with the 
other two gave no statistically significant improvement (p > 
0.05 in both cases); therefore, we decided to use the random 
C because of its simplicity. Diagnostic analysis of residuals 
did not reveal serious lack of normality, which was veri-
fied also by a formal Shapiro test of normality (p > 0.05) 
or heteroscedasticity confirmed by a Levene test (p > 0.05). 
Using the values of second-order coefficients a minimum 
stiffness can be predicted at about the 13th week. Similar 
observations can be made about SR vs. time and pRoM vs. 
Figure 1 - Point Shear Wave Elastography.
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time relationships; in both cases we observed a parabolic 
trend with minimum values at the 9th week follow-up and 
a gradual return to the pre-ESWT measures throughout the 
15 following weeks. LME modelling allows to predict mini-
mum values at the 13th week also with regard to soleus SR 
and ankle pROM. Figure 4 shows the scatterplot of EI vs. 
MAS for each patient in separate panels and highlights the 
close correlation between the two parameters. 
DISCUSSION 
P-SWE confirmed that extracorporeal shockwaves can 
reduce muscle contracture in children with CP. Post ESWT 
there was statistically significant improvement in SR and 
EI. The statistical model (LME) showed that the lowest 
level of muscle stiffness was attained in the 9th week after 
completion of treatment, and that the effect disappeared by 
the 24th week. The model also predicted that the effects 
of ESWT would be highest at the 13th week. Furthermore, 
the repeated-measures correlation analysis found positive 
correlation between MAS score and EI. 
Our findings should be now compared with those of simi-
lar previous studies which consider the same type of shock 
waves, namely the extracorporeal shock waves, and the 
same kind of disorder, that is to say CP. Papers about radi-
Figure 2 - Soleus muscle Elasticity Index (EI) expressed in 
kilopascal as a function of time expressed in weeks. Points 
represent data from each patient while solid line represents 
mean. 
Figure 3 - Soleus muscle Elasticity Index (EI) expressed in 
kilopascal as a function of time expressed in weeks. To each 
patient is reported its own panel.
Figure 4 - Relation between soleus muscle Elasticity Index 
(EI) expressed in kilopascal and soleus muscle MAS score. To 
each patient is reported its own panel.
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al waves or post-stroke spasticity were fully excluded from 
comparative analysis. It should be made clear our study 
was the first ever that evaluated the efficacy of defocused 
extracorporeal shockwaves on spastic muscles, whereas all 
previous studies have reported the effects of focused shock-
waves. Focused and defocused extracorporeal shock waves 
share both physical basis and biological effects. However, 
it is well known that defocused shockwaves are the most 
suitable for treatment of muscle disorders, especially since 
they allow to treat a larger area at the same time. This is 
the reason why the energy level we used in this experimen-
tal study was definitely higher than that used by previous 
researchers. It is also necessary to state that the P-SWE 
method we used in this research, namely the S-SWE, has 
never been employed for the evaluation of ESWT effects on 
spastic muscles. S-SWE allows the most accurate measure-
ments of tissue stiffness compared to other SWE methods, 
according to the manufacturer. 
In the 2010 self-controlled trial by Amelio and Manganotti 
(15) a single active shockwave stimulation (1500 SW, ener-
gy level 0.030 mJ/mm2, frequency not specified) produced 
a significant 4-week-long reduction in the hypertonia of the 
plantar flexors of 12 children with CP. Although their study 
included a control group, the small sample size, the short-
term follow-up (4 weeks), and the use of only subjective 
(MAS and ankle pRoM) or nonstandardized (baropodom-
etry) measures of muscle stiffness represent important 
limitations compared to our research. In a 2014 study on a 
large group of 64 children with CP, Mirea et al. (12) showed 
that ESWT (3 sessions, 500 SW per session, energy level 
0.15 mJ/mm2, frequency 10 Hz) could decrease muscle 
spasticity at different anatomical sites. Although the sample 
size was large, the lack of a control group, the treatment 
of different muscles, the use of only subjective assessment 
tools (MAS, Gross Motor Function Classification System, 
Gross Motor Function Measure 66, and Questionnaire on 
Pain caused by spasticity), and the short-term follow-up are 
important weaknesses. El-Shamy et al. (14) in 2014 showed 
that ESWT (12 sessions at weekly intervals, 1500 SW, ener-
gy level 0.030 mJ/mm2, frequency 5 Hz) could improve 
plantar flexors spasticity and gait pattern in children with 
CP. The randomized controlled design and the use of gait 
analysis for assessment represent the main strengths of their 
study. Nevertheless, there were some important limitations, 
for example, the large number of ESWT sessions and the 
single follow-up at the end of the treatment. In 2015 Park 
and co-authors (11), for the first time, used ultrasonography 
to study the effectiveness of ESWT (1 vs. 3 sessions, 1500 
SW per session, energy level 0.030 mJ/mm2, frequency 4 
Hz) for reducing hypertonicity of the medial gastrocnemius 
in children with CP. Their case-control study had a relative-
ly small sample size (n = 12) and short follow-up (4 weeks). 
Moreover, they used the TE technique, which is operator 
dependent (because the stress applied can vary) and lacks 
precision in the color-coded graphic representation of stiff-
ness. Picelli et al. (13) in 2017 proved that the combina-
tion of botulinum toxin serotype A (BoNT-A) and ESWT 
(1 session per week for 3 weeks, 1500 SW per session, ener-
gy level 0.030 mJ/mm2, frequency 4 Hz) is more effective 
than BoNT-A alone for treatment of spasticity of different 
muscles in a group of 10 children with CP. Follow-up lasted 
4 weeks and assessment of the stiffness was with SWE. The 
randomized controlled design and the use of SWE are the 
main strengths of Picelli’s study. However, the small sample 
size, the short-term follow up, the use of ESWT in associa-
tion with BoNT-A, and the employment of SR (semi-quan-
titative assessment) as the only elastographic outcome 
represent important limitations compared to our study.
The main strengths of this study were the use of an oper-
ator-independent instrument (P-SWE) to measure muscle 
stiffness and the long-term follow-up. However, this study 
has two main limitations. First, the sample size was small (n 
= 25); nevertheless, it should be noted that it is the largest 
study to date using ultrasonography to measure the effect 
of ESWT on CP hypertonic muscles. Second, a causal rela-
tionship cannot be established because of the observational 
nature of the study. Performing clinical trials in children is 
difficult because of heterogeneity of the population and the 
particular ethical concerns in this age-group, such as protec-
tion against unknown risks and harms (25).
The present study has two important implications for clini-
cians. First, we have confirmed once again that ESWT (in 
particular defocused shockwaves) is effective for manag-
ing muscles contractures in children with CP. The maxi-
mal effect occurs at 13 weeks post treatment, after which 
the effects progressively decline until the 24th week. Thus, 
it may be reasonable to apply ESWT at least twice a year. 
Second, it is advisable to use an objective assessment tool, 
such US elastography, for clinical evaluation of muscle 
spasticity in children with CP. In particular, P-SWE 
should be used to measure the passive component of spas-
tic muscle contracture (muscle fibrosis), which is barely 
assessed by MAS.
The authors are awaiting Ethical Committee approval for a 
randomized controlled trial, with a control group treated by 
sham ESWT. 
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